The increasing adoption of telomere performance programs for leading a healthy life; growing focus on increasing healthy life expectancy (HALE); increasing government focus towards preventive healthcare; rising geriatric population and the subsequent growth in the need for cellular health screening; increasing research activities; growing adoption of the direct-to-consumer approach for the availability of kits; and increasing burden of chronic diseases are the major factors that are expected to drive the growth of the cellular health screening market.
Based on type, the global cellular health screening market is segmented into single test panels and multi-test panels. In 2017, the single test panels segment is expected to account for the largest share of the global cellular health screening market. These panels are used to get accurate information about a single biomarker and understand how it affects the health of an individual.
By sample collection site, the global cellular health screening market is segmented into at-home, in-office, and other sample collection sites. The at-home segment is expected to register the highest CAGR during the forecast period.
- In 2016, the Telomere Diagnostics (US) launched the TeloYears genetic test, which helps track the cellular age of an individual based on the telomere length.
- The Life Length (Spain) partnered with Eastern Biotech & Life Sciences (Dubai) in 2016 and Freiburg Medical Laboratory Middle East (FML) (Dubai) in 2014 to expand its business in the Middle East.
For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=227041930